| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification
|
Angevin, Eric
|
|
2017
|
87 |
C |
p. 131-139
|
artikel
|
| 2 |
COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss
|
Crabb, Simon J.
|
|
2017
|
87 |
C |
p. 75-83
|
artikel
|
| 3 |
Colchicine is an active treatment for everolimus-induced oral ulcers
|
Ropert, Stanislas
|
|
2017
|
87 |
C |
p. 209-211
|
artikel
|
| 4 |
Corrigendum to “Avoidable cancer cases in the Nordic countries – The impact of overweight and obesity” [Eur J Cancer 79 (2017) 106–118]
|
Andersson, Therese M.-L.
|
|
2017
|
87 |
C |
p. 219-220
|
artikel
|
| 5 |
‘Corrigendum to “Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulins” [Eur J Cancer 81 (August 2017) 203–205]’
|
Spänkuch, Iris
|
|
2017
|
87 |
C |
p. 221
|
artikel
|
| 6 |
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial
|
Schöffski, Patrick
|
|
2017
|
87 |
C |
p. 147-163
|
artikel
|
| 7 |
Diarrhoea during checkpoint blockade, not always colitis
|
Koldenhof, Josephine J.
|
|
2017
|
87 |
C |
p. 216-218
|
artikel
|
| 8 |
European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancers
|
Plaschke, Christina Caroline
|
|
2017
|
87 |
C |
p. 172-181
|
artikel
|
| 9 |
Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer
|
Le Rhun, Emilie
|
|
2017
|
87 |
C |
p. 189-198
|
artikel
|
| 10 |
Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria
|
Madu, Max F.
|
|
2017
|
87 |
C |
p. 212-215
|
artikel
|
| 11 |
Immune checkpoint inhibitor–associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?
|
Strik, Herwig
|
|
2017
|
87 |
C |
p. 205-208
|
artikel
|
| 12 |
In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies?
|
Aspeslagh, Sandrine
|
|
2017
|
87 |
C |
p. 65-74
|
artikel
|
| 13 |
Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohort
|
Forissier, Violaine
|
|
2017
|
87 |
C |
p. 47-57
|
artikel
|
| 14 |
Letter to the Editor regarding the paper by F. Cardoso et al. ‘European Breast Cancer Conference manifesto on breast centres/units’
|
Saguatti, Gianni
|
|
2017
|
87 |
C |
p. 199-200
|
artikel
|
| 15 |
Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives
|
Roth, Gaël S.
|
|
2017
|
87 |
C |
p. 101-112
|
artikel
|
| 16 |
Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival
|
Temkin, Sarah M.
|
|
2017
|
87 |
C |
p. 182-188
|
artikel
|
| 17 |
Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases
|
Loriot, Y.
|
|
2017
|
87 |
C |
p. 140-146
|
artikel
|
| 18 |
Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial
|
Verlingue, Loic
|
|
2017
|
87 |
C |
p. 122-130
|
artikel
|
| 19 |
Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer
|
Criscitiello, Carmen
|
|
2017
|
87 |
C |
p. 164-171
|
artikel
|
| 20 |
Re: Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists
|
Albertsen, Peter C.
|
|
2017
|
87 |
C |
p. 203
|
artikel
|
| 21 |
Recurrence dynamics of breast cancer according to baseline body mass index
|
Biganzoli, Elia
|
|
2017
|
87 |
C |
p. 10-20
|
artikel
|
| 22 |
Reply to letter from Suguatti et al.
|
Cataliotti, Luigi
|
|
2017
|
87 |
C |
p. 201-202
|
artikel
|
| 23 |
Response to letter – Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists
|
Scailteux, Lucie-Marie
|
|
2017
|
87 |
C |
p. 204
|
artikel
|
| 24 |
Risk of early-onset prostate cancer associated with occupation in the Nordic countries
|
Barry, Kathryn Hughes
|
|
2017
|
87 |
C |
p. 92-100
|
artikel
|
| 25 |
Site of childhood cancer care in the Netherlands
|
Reedijk, A.M.J.
|
|
2017
|
87 |
C |
p. 38-46
|
artikel
|
| 26 |
Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon
|
Legué, Laura M.
|
|
2017
|
87 |
C |
p. 84-91
|
artikel
|
| 27 |
The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies
|
Beer, Tomasz M.
|
|
2017
|
87 |
C |
p. 21-29
|
artikel
|
| 28 |
The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study
|
Holm-Rasmussen, Emil Villiam
|
|
2017
|
87 |
C |
p. 1-9
|
artikel
|
| 29 |
The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer
|
Anderson, R.A.
|
|
2017
|
87 |
C |
p. 58-64
|
artikel
|
| 30 |
Time to diagnosis and treatment for cancer patients in the Netherlands: Room for improvement?
|
Helsper, Charles (C.W.)
|
|
2017
|
87 |
C |
p. 113-121
|
artikel
|
| 31 |
Weekly cabazitaxel plus prednisone is effective and less toxic for ‘unfit’ metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial
|
Climent, Miguel Ángel
|
|
2017
|
87 |
C |
p. 30-37
|
artikel
|
Tijdschrift beschrijving